Diana Rocha-Mendoza

Diana Rocha-Mendoza


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2010 in Critical Reviews in Microbiology
Verified
Journal Article
Closed access
PDF file
BRBeatriz Ruiz-Villafan
Beatriz Ruiz-Villafan
ACAdán Chávez
Adán Chávez
AFAngela Forero
Angela Forero
YGYolanda García-Huante
Yolanda García-Huante
ARAlba Romero
Alba Romero
ELElizabeth Langley
Elizabeth Langley
Microbial secondary metabolites are low molecular mass products, not essential for growth of the producing cultures, but very important for human health. They include antibiotics, antitumor agents, cholesterol-lowering drugs, and others. They have unusual structures and are usually formed during the late growth phase of the producing microorganisms. Its synthesis can be influenced greatly by manipulating the type and concentration of the nutrients formulating the culture media. Among these nutrients, the effect of the carbon sources has been the subject of continuous studies for both, industry and research groups. Different mechanisms have been described in bacteria and fungi to explain the negative carbon catabolite effects on secondary metabolite production. Their knowledge and manipulation have been useful either for setting fermentation conditions or for strain improvement. During the last years, important advances have been reported on these mechanisms at the biochemical and molecular levels. The aim of the present review is to describe these advances, giving special emphasis to those reported for the genus Streptomyces.

28 July 2010 in The Journal of Antibiotics
Verified
Journal Article
Closed access
Sergio SánchezSergio Sánchez
Sergio Sánchez
ACAdán Chávez
Adán Chávez
AFAngela Forero
Angela Forero
YGYolanda García-Huante
Yolanda García-Huante
ARAlba Romero
Alba Romero
BRBeatriz Ruiz-Villafan
Beatriz Ruiz-Villafan

27 April 2019 in Applied Microbiology and Biotechnology
Verified
Journal Article
Open access
PDF file
IGIsrael Garcia-Cano
Israel Garcia-Cano
DRDiana Rocha-Mendoza
Diana Rocha-Mendoza
JOJoana Ortega-Anaya
Joana Ortega-Anaya
KWKaren Wang
Karen Wang
EKErica Kosmerl-Delaney
Erica Kosmerl-Delaney
RJRafael Jimenez-Flores
Rafael Jimenez-Flores
Regular consumption of fermented dairy products helps maintain a healthy microbiota and prevent gut dysbiosis-linked diseases. The lactic acid bacteria (LAB) present in food enhance the digestibility of proteins, moderate the release of fatty acids, and support human health through inhabiting the gastrointestinal tract. These desirable properties of LAB are attributed, in part, to their metabolic processes involving enzymes such as lipases, proteases, and antibacterial proteins. The LAB strains presenting higher enzymatic activities may offer improved functionality for applications in foods. The first aim of this work was to isolate and identify LAB from diverse dairy products and select those with enhanced enzymatic activities. Secondly, this work aimed to investigate the subcellular organization and identity of these enzymes after semi-purification. Out of the total 137 LAB strains isolated and screened, 50.3% and 61.3% of the strains exhibited lipolytic and proteolytic activities, respectively. Seven strains displaying high enzymatic activities were selected and further characterized for the cellular organization of their lipases, proteases, and antibacterial proteins. The lipolytic and proteolytic activities were exhibited predominantly in the extracellular fraction; whereas, the antibacterial activities were found in various cellular fractions and were capable of inhibiting common undesirable microorganisms in foods. In total, two lipases, seven proteases, and three antibacterial proteins were identified by LC-MS/MS. Characterization of LAB strains with high enzymatic activity has potential biotechnological significance in fermentative processes and in human health as they may improve the physicochemical characteristics of foods and displace strains with weaker enzymatic activities in the human gut microbiota.

1 January 2006 in Free Radical Research
Verified
Journal Article
Closed access
EFEsaú Floriano-Sánchez
Esaú Floriano-Sánchez
CVCleva Villanueva
Cleva Villanueva
OMOmar Noel Medina-Campos
Omar Noel Medina-Campos
DRDiana Rocha-Mendoza
Diana Rocha-Mendoza
Dolores Javier Sánchez GonzálezDolores Javier Sánchez González
Dolores Javier Sánchez González
José Pedraza-ChaverriJosé Pedraza-Chaverri
José Pedraza-Chaverri
The antioxidant nordihydroguaiaretic acid (NDGA) has recently become well known as a putative anticancer drug. In this paper, it was evaluated the in vitro peroxynitrite (ONOO− ), singlet oxygen (1O2), hydroxyl radical (OH√), hydrogen peroxide (H2O2), superoxide anion and hypochlorous acid (HOCl) scavenging capacity of NDGA. It was found that NDGA scavenges: (a) ONOO− (IC50 = 4 ± 0.94 μM) as efficiently as uric acid; (b) 1O2 (IC50 = 151 ± 20 μM) more efficiently than dimethyl thiourea, lipoic acid, N-acetyl-cysteine and glutathione; (c) OH√ (IC50 = 0.15 ± 0.02 μM) more efficiently than dimethyl thiourea, uric acid, trolox, dimethyl sulfoxide and mannitol, (d) (IC50 = 15 ± 1 μM) more efficiently than N-acetyl-cysteine, glutathione, tempol and deferoxamine and (e) HOCl (IC50 = 622 ± 42 μM) as efficiently as lipoic acid and N-acetyl-cysteine. NDGA was unable to scavenge H2O2. In an in vivo study in rats, NDGA was able to prevent ozone-induced tyrosine nitration in lungs. It is concluded that NDGA is a potent in vitro scavenger of ONOO− , 1O2, OH√, and HOCl and is able to prevent lung tyrosine nitration in vivo.

9 February 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
EKErica Kosmerl-Delaney
Erica Kosmerl-Delaney
DRDiana Rocha-Mendoza
Diana Rocha-Mendoza
JOJoana Ortega
Joana Ortega
RJRafael Jimenez-Flores
Rafael Jimenez-Flores
IGIsrael Garcia-Cano
Israel Garcia-Cano
The milk fat globule membrane (MFGM), the component that surrounds fat globules in milk, and its constituents have gained significant attention for their gut function, immune-boosting properties, and cognitive-development roles. The MFGM can directly interact with probiotic bacteria, such as bifidobacteria and lactic acid bacteria (LAB), through interactions with bacterial surface proteins. With these interactions in mind, increasing evidence supports a synergistic effect between MFGM and probiotics to benefit human health at all ages. This important synergy affects the survival and adhesion of probiotic bacteria through gastrointestinal transit, mucosal immunity, and neurocognitive behavior in developing infants. In this review, we highlight the current understanding of the co-supplementation of MFGM and probiotics with a specific emphasis on their interactions and colocalization in dairy foods, supporting in vivo and clinical evidence, and current and future potential applications.

31 March 2018 in Antonie van Leeuwenhoek
Verified
Journal Article
Closed access
PDF file
ARAlba Romero-Rodríguez
Alba Romero-Rodríguez
NCNidia Maldonado Carmona
Nidia Maldonado Carmona
BRBeatriz Ruiz-Villafán
Beatriz Ruiz-Villafán
Niranjan KoiralaNiranjan Koirala
Niranjan Koirala
DRDiana Rocha-Mendoza
Diana Rocha-Mendoza
SSSergio Sánchez
Sergio Sánchez